Regencell Bioscience Holdings Limited

NasdaqCM:RGC

Location

Market Cap

USD 11.37 B

Share Price

USD 18.43

Avg Daily Volume

700,338

Change (1 day)

-19.84%

Change (1 year)

407.71%

Change (YTD)

273.08%

Regencell Bioscience Holdings Limited Gross Profit Margin for the Trailing 12 Months (TTM) ending July 08, 2025: N/A

Regencell Bioscience Holdings Limited Gross Profit Margin is NA for the Trailing 12 Months (TTM) ending July 08, 2025. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
Key Data
Date Gross Profit Margin EBIT Margin EBITDA Margin Net Income Margin